{"id":10057,"date":"2026-06-02T13:53:01","date_gmt":"2026-06-02T10:53:01","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=10057"},"modified":"2026-06-02T13:53:01","modified_gmt":"2026-06-02T10:53:01","slug":"europcr-2026-dominates-tctmds-top-cardiovascular-stories-of-may","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/europcr-2026-dominates-tctmds-top-cardiovascular-stories-of-may\/","title":{"rendered":"EuroPCR 2026 Dominates TCTMD\u2019s Top Cardiovascular Stories of May"},"content":{"rendered":"

EuroPCR 2026 Dominates TCTMD\u2019s Top Cardiovascular Stories of May<\/span><\/p>\n

Source: TCTMD Editor\u2019s Corner | June 1, 2026<\/span><\/p>\n

1. EuroPCR 2026 \u2013 Immediate Complete PCI May Harm STEMI Patients With Multivessel CAD<\/span><\/p>\n

* Findings support a staged PCI strategy rather than immediate complete revascularization in STEMI patients with multivessel coronary disease.<\/span><\/p>\n

2. EuroPCR 2026 \u2013 evolocumab Reduces Cardiovascular Events After PCI<\/span><\/p>\n

* More intensive LDL-cholesterol lowering with the PCSK9 inhibitor evolocumab reduced major CV events in high-risk patients with prior PCI.<\/span><\/p>\n

3. EuroPCR 2026 \u2013 Self-Expanding TAVR Valves Show Better Hemodynamics<\/span><\/p>\n

* In patients with small aortic annuli, self-expanding valves provided better valve performance at 3 years, although clinical outcomes remained similar.<\/span><\/p>\n

4. HRS 2026 \u2013 Rare Fatal Arrhythmias Reported After PFA<\/span><\/p>\n

* Rare fatal ventricular arrhythmias were identified following pulsed-field ablation (PFA), highlighting the need for further safety evaluation.<\/span><\/p>\n

5. EuroPCR 2026 \u2013 PCI vs CABG for Left Main Disease: 10-Year Outcomes<\/span><\/p>\n

* Long-term survival was similar after PCI or coronary bypass surgery for left main coronary artery disease.<\/span><\/p>\n

6. SCAI 2026 \u2013 Higher Lp(a) Levels Linked to Greater Risk<\/span><\/p>\n

* Cardiovascular risk increased above 125 nmol\/L, with the strongest association with death and stroke observed at Lp(a) levels \u2265175 nmol\/L.<\/span><\/p>\n

7. EuroPCR 2026 \u2013 New Technologies Improve Treatment of Heavily Calcified Coronary Arteries<\/span><\/p>\n

* Techniques such as shockwave therapy (IVL) and atherectomy are helping physicians better prepare heavily calcified arteries before stent implantation, improving procedural success.<\/span><\/p>\n

8. EuroPCR 2026 \u2013 Novel Adaptive Coronary Implant Shows Excellent 4-Year Outcomes<\/span><\/p>\n

* Unlike conventional metallic stents, this device is designed to allow the artery to adapt and move more naturally over time, with excellent 4-year outcomes..<\/span><\/p>\n

9. FDA Approves Baxdrostat for Uncontrolled Hypertension<\/span><\/p>\n

* Baxdrostat became the first approved aldosterone synthase inhibitor for patients with inadequately controlled hypertension.<\/span><\/p>\n

10. SCAI 2026 \u2013 Clopidogrel Monotherapy Gains Support After DAPT<\/span><\/p>\n

* A large study added support for clopidogrel monotherapy following DAPT cessation, reinforcing a growing trend in clinical practice.<\/span><\/p>\n

Key Message:<\/span>
\nEuroPCR 2026 dominated cardiovascular news in May 2026, with additional major updates emerging from HRS 2026, SCAI 2026, and the FDA approval of baxdrostat for hypertension.<\/span><\/p>\n

http:\/\/www.tctmd.com\/news\/tctmds-top-10-most-popular-stories-may-2026<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

EuroPCR 2026 Dominates TCTMD\u2019s Top Cardiovascular Stories of May Source: TCTMD Editor\u2019s Corner | June 1, 2026 1. EuroPCR 2026 \u2013 Immediate Complete PCI May Harm STEMI Patients With Multivessel CAD * Findings support a staged PCI strategy rather than immediate complete revascularization in STEMI patients with multivessel coronary disease. 2. EuroPCR 2026 \u2013 evolocumab […]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10057","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=10057"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10057\/revisions"}],"predecessor-version":[{"id":10058,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10057\/revisions\/10058"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=10057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=10057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=10057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}